Viewing Study NCT05047458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-03-04 @ 9:56 AM
Study NCT ID: NCT05047458
Status: COMPLETED
Last Update Posted: 2021-09-17
First Post: 2021-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Single-dose ALXN2050 in Healthy Adults
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Factor D Inhibitor View
None Complement View
None ALXN2050 View
None ACH-0145228 View
None Pharmacokinetics View
None Pharmacodynamics View
None Safety View